Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Control of Alcohol Evaporation Loss – V 2.0

Posted on By

Elixir Department: SOP for Control of Alcohol Evaporation Loss – V 2.0

Standard Operating Procedure for Control of Alcohol Evaporation Loss During Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/091/2025
Supersedes SOP/ELX/091/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure to minimize and control the evaporation loss of alcohol during the manufacturing of elixirs to ensure accurate alcohol content in the final product and compliance with quality standards.

2. Scope

This SOP is applicable to all elixir formulations containing alcohol (ethanol, isopropanol, etc.) as an excipient or solvent, manufactured in the Elixir Department.

3. Responsibilities

  • Production Operator:
    • Follow instructions to minimize alcohol exposure and document batch-related observations.
  • Production Supervisor:
    • Ensure all control measures are implemented and verified during manufacturing.
  • QA Officer:
    • Verify alcohol retention data and approve release based on final content assay.
See also  Elixir Department: SOP for Preventive Maintenance of Mixing Vessels - V 2.0

4. Accountability

The Head of Production is accountable for ensuring implementation of all necessary controls to reduce evaporation loss and maintain product quality and safety.

5. Procedure

5.1 Material and Equipment

Controls
  1. Use alcohols that meet pharmacopeial specifications and store them in tightly sealed containers.
  2. Ensure all manufacturing tanks and containers used in alcohol-based elixir manufacturing are fitted with proper lids, seals, or nitrogen blanketing systems.
  3. Use closed-loop transfer systems or stainless-steel transfer lines with minimal exposure to the environment.

5.2 Manufacturing Controls

  1. Maintain room temperature within validated limits (not more than 25°C unless otherwise specified).
  2. Minimize holding time after alcohol addition by proceeding directly to the next step (e.g., mixing or sealing).
  3. Ensure continuous agitation during alcohol mixing to prevent stratification and to avoid prolonged surface exposure.
  4. Use nitrogen blanketing for storage tanks and mixing vessels wherever applicable to reduce evaporation risk.

5.3 Monitoring Alcohol Content

  1. Record quantity of alcohol added and final batch volume in the BMR.
  2. Sample the batch for alcohol assay and record the test result on the Alcohol Content Report (Annexure-1).
  3. Allowable alcohol loss: typically within ±5% of theoretical value unless specified by regulatory requirement.

5.4 Corrective Actions

  1. If alcohol loss exceeds permissible limits, investigate immediately and document in the Deviation Record.
  2. Adjust alcohol content if allowed by process control procedures, and document final concentration.
  3. If adjustment is not permissible, the batch shall be held and disposition decided by QA.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • IP: Indian Pharmacopoeia

7. Documents

  1. Alcohol Content Report (Annexure-1)
  2. Batch Manufacturing Record (BMR)
  3. Deviation Record (if applicable)

8. References

  • IP/USP Monographs for Alcohol
  • 21 CFR Part 211.105 – Equipment Identification and Control
  • WHO TRS 1010 – GMP for Pharmaceutical Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Alcohol Content Report

Date Batch No. Alcohol Type Theoretical Content (%) Observed Content (%) Deviation (%) Remarks
11/04/2025 ELX-1030 Ethanol IP 12.0% 11.4% -5.0% Within limit

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added nitrogen blanketing and deviation handling Process Optimization QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: Mass Spectral Fragmentation Analysis SOP – V 2.0
Next Post: Biosimilars: SOP for Cleaning and Sanitization of Bioreactors – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version